Literature DB >> 33850837

Are We Overradiating Patients with Irritable Bowel Syndrome?

Yousaf B Hadi1, Adnan Aman Khan1, Syeda F Z Naqvi1, Salman Khan1, Jesse Thompson1, Justin T Kupec1.   

Abstract

INTRODUCTION: Protracted exposures to small doses of radiation, even cumulative effective doses (CED) as low as 50-100 mSv, may increase the risk for malignancy. Medical radiation exposure has not been rigorously examined for patients with irritable bowel syndrome (IBS). We examined medical radiation exposure in patients with IBS at a tertiary care center in the USA.
METHODS: Patients diagnosed with IBS at our institute from 2009 to 2018 were included in a retrospective cohort study. Medical charts were examined to calculate total and annual CED.
RESULTS: 221 patients were included; mean CED was 40.32 mSv (SD: 54.36). Fifty-nine participants (26.7%) received >50 mSv of CED with 27 participants (12.2%) exceeding 100 mSv. Conventional imaging, nuclear medicine, and fluoroscopy accounted for 74.08, 12.93, and 12.98% of total CED, respectively. CT scans contributed to 66.61% of total CED. Outpatient orders accounted for 37.96% of total CED, while 31.4% of total CED was ordered in the emergency department. Population-specific high total CED was calculated as 105.65 mSv. Multivariable binomial logistic regression model found that comorbid anxiety, chronic pain medication use, and diarrhea-predominant IBS were independently positively associated with population-specific high CED exposure. No significant temporal trend in peri-diagnostic mean CED was found.
CONCLUSION: Patients with IBS receive high amounts of medical radiation, with 1 in 4 patients reaching at-risk levels of 50 mSv or more. Usage of pain medication at home, comorbid anxiety, and IBS-D are independently linked to an increased risk of high CED.
Copyright © 2020 by S. Karger AG, Basel.

Entities:  

Keywords:  Cancer; Diagnostic imaging; Irritable bowel syndrome; Medical radiation

Year:  2020        PMID: 33850837      PMCID: PMC8015257          DOI: 10.1159/000511105

Source DB:  PubMed          Journal:  Inflamm Intest Dis        ISSN: 2296-9365


  14 in total

1.  Risk of cancer from diagnostic X-rays: estimates for the UK and 14 other countries.

Authors:  Amy Berrington de González; Sarah Darby
Journal:  Lancet       Date:  2004-01-31       Impact factor: 79.321

2.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

Review 3.  Diagnostic imaging and radiation exposure in inflammatory bowel disease.

Authors:  Nekisa Zakeri; Richard C G Pollok
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

4.  Radiation exposure from diagnostic imaging among patients with gastrointestinal disorders.

Authors:  Alan N Desmond; Sebastian McWilliams; Michael M Maher; Fergus Shanahan; Eamonn M Quigley
Journal:  Clin Gastroenterol Hepatol       Date:  2011-11-12       Impact factor: 11.382

5.  Radiation exposure in patients with inflammatory bowel disease and irritable bowel syndrome in the years 2001-2011.

Authors:  Hanna Englund; Katarina Lidén K; Torbjörn Lind; Torbjörn Sundström; Pontus Karling
Journal:  Scand J Gastroenterol       Date:  2016-11-10       Impact factor: 2.423

6.  Quantifying exposure to diagnostic medical radiation in patients with inflammatory bowel disease: are we contributing to malignancy?

Authors:  E Newnham; E Hawkes; A Surender; S L James; R Gearry; P R Gibson
Journal:  Aliment Pharmacol Ther       Date:  2007-10-01       Impact factor: 8.171

Review 7.  Cancer and non-cancer effects in Japanese atomic bomb survivors.

Authors:  M P Little
Journal:  J Radiol Prot       Date:  2009-05-19       Impact factor: 1.394

Review 8.  Irritable bowel syndrome: relations with functional, mental, and somatoform disorders.

Authors:  Constanze Hausteiner-Wiehle; Peter Henningsen
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

9.  Risk factors for radiation exposure in newly diagnosed IBD patients.

Authors:  David J Grand; Adam Harris; Jason Shapiro; Edmund Wu; Julie Giacalone; Bruce E Sands; Renee Bright; Heather Moniz; Meaghan Mallette; Neal Leleiko; Sylvan Wallenstein; Zahid Samad; Marjorie Merrick; Samir A Shah
Journal:  Abdom Radiol (NY)       Date:  2016-07

10.  Cancer risks attributable to low doses of ionizing radiation: assessing what we really know.

Authors:  David J Brenner; Richard Doll; Dudley T Goodhead; Eric J Hall; Charles E Land; John B Little; Jay H Lubin; Dale L Preston; R Julian Preston; Jerome S Puskin; Elaine Ron; Rainer K Sachs; Jonathan M Samet; Richard B Setlow; Marco Zaider
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.